open access

Vol 14, No 1 (2019)
Review Papers
Published online: 2019-04-10
Get Citation

New biomarkers in cardiology — are we on the right track?

Agata Tymińska, Krzysztof J. Filipiak
Folia Cardiologica 2019;14(1):60-66.

open access

Vol 14, No 1 (2019)
Review Papers
Published online: 2019-04-10

Abstract

There are many markers for the risk assessment of cardiovascular diseases. New sensitive and specific biomarkers that could help stratify risk, in both healthy and cardiovascular populations, are still being sought. Galectin 3 and ST-2 seem to be very promising molecules. However, further research is needed to establish their full diagnostic and prog- nostic value. We present a review of the literature showing the possibility of comprehensive use of both biomarkers, especially in coronary artery disease. Galectin-3 and ST-2, through their association with fibrotic processes, may prove to be beneficial in patients with coronary disease and following myocardial infarction. 

Abstract

There are many markers for the risk assessment of cardiovascular diseases. New sensitive and specific biomarkers that could help stratify risk, in both healthy and cardiovascular populations, are still being sought. Galectin 3 and ST-2 seem to be very promising molecules. However, further research is needed to establish their full diagnostic and prog- nostic value. We present a review of the literature showing the possibility of comprehensive use of both biomarkers, especially in coronary artery disease. Galectin-3 and ST-2, through their association with fibrotic processes, may prove to be beneficial in patients with coronary disease and following myocardial infarction. 
Get Citation

Keywords

cardiovascular diseases; coronary artery disease; galectin-3; myocardial infarction; remodelling; ST-2

About this article
Title

New biomarkers in cardiology — are we on the right track?

Journal

Folia Cardiologica

Issue

Vol 14, No 1 (2019)

Pages

60-66

Published online

2019-04-10

Bibliographic record

Folia Cardiologica 2019;14(1):60-66.

Keywords

cardiovascular diseases
coronary artery disease
galectin-3
myocardial infarction
remodelling
ST-2

Authors

Agata Tymińska
Krzysztof J. Filipiak

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl